US equities |
MU $1,046.60 ▼-3.81% NVDA $231.12 ▼-2.68% SNDK $1,622.00 ▼-4.16% AMD $620.50 ▼-3.93% INTC $106.77 ▼-5.62% SPCX $162.29 ▼-3.17% META $718.34 ▼-0.41% PLTR $197.49 ▲+1.74%
FinancialContent

Latest News about Phase 2B

Recent news which mentions Phase 2B

Ionis Pharma Announces Publication Of Positive Donidalorsen Data For Angioedema Attacks
Tickers IONS
Tags Biotech Benzinga General
From Benzinga